HomeMarketsDiscoverWatchlistPortfoliosScreener
Sign Up or Login
  • Israel

Israeli Biotech Stock News

TASE:EVGN
TASE:EVGNBiotechs

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

March 13, 2023
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
TASE:KMDA
TASE:KMDABiotechs

Is Kamada (TLV:KMDA) Using Too Much Debt?

January 26, 2023
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
TASE:KMDA
TASE:KMDABiotechs

We Discuss Why Kamada Ltd.'s (TLV:KMDA) CEO Compensation May Be Closely Reviewed

December 16, 2022
Key Insights Kamada to hold its Annual General Meeting on 22 December 2022 CEO Amir London's total compensation...
TASE:BONS
TASE:BONSBiotechs

Is Bonus BioGroup (TLV:BONS) In A Good Position To Deliver On Growth Plans?

December 13, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
TASE:CBI
TASE:CBIBiotechs

Clal Biotechnology Industries Third Quarter 2022 Earnings: ₪0.015 loss per share (vs ₪0.12 loss in 3Q 2021)

December 01, 2022
Clal Biotechnology Industries ( TLV:CBI ) Third Quarter 2022 Results Key Financial Results Revenue: ₪5.70m (down 72...
TASE:CANF
TASE:CANFBiotechs

Can-Fite BioPharma Third Quarter 2022 Earnings: US$0.003 loss per share (vs US$0.006 loss in 3Q 2021)

November 27, 2022
Can-Fite BioPharma ( TLV:CANF ) Third Quarter 2022 Results Key Financial Results Net loss: US$2.53m (loss narrowed by...
TASE:KMDA
TASE:KMDABiotechs

Kamada Third Quarter 2022 Earnings: EPS: US$0.01 (vs US$0.02 loss in 3Q 2021)

November 24, 2022
Kamada ( TLV:KMDA ) Third Quarter 2022 Results Key Financial Results Revenue: US$32.2m (up 40% from 3Q 2021). Net...
TASE:EVGN
TASE:EVGNBiotechs

Evogene Third Quarter 2022 Earnings: US$0.16 loss per share (vs US$0.19 loss in 3Q 2021)

November 22, 2022
Evogene ( TLV:EVGN ) Third Quarter 2022 Results Key Financial Results Net loss: US$6.54m (loss narrowed by 14% from 3Q...
TASE:KMDA
TASE:KMDABiotechs

Further weakness as Kamada (TLV:KMDA) drops 10% this week, taking three-year losses to 13%

September 23, 2022
For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...
TASE:BONS
TASE:BONSBiotechs

Bonus BioGroup Ltd.'s (TLV:BONS) most bullish insider is CEO Shai Meretzki, and their holdings value went up by 33% last week

August 18, 2022
A look at the shareholders of Bonus BioGroup Ltd. ( TLV:BONS ) can tell us which group is most powerful. And the group...
TASE:CBI
TASE:CBIBiotechs

Calculating The Fair Value Of Clal Biotechnology Industries Ltd. (TLV:CBI)

July 14, 2022
How far off is Clal Biotechnology Industries Ltd. ( TLV:CBI ) from its intrinsic value? Using the most recent financial...
TASE:CANF
TASE:CANFBiotechs

Is Can-Fite BioPharma (TLV:CANF) In A Good Position To Invest In Growth?

June 30, 2022
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
TASE:BLRX
TASE:BLRXBiotechs

Is BioLineRx (TLV:BLRX) A Risky Investment?

June 17, 2022
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
TASE:HDST
TASE:HDSTBiotechs

Hadasit Bio-Holdings (TLV:HDST) Strong Profits May Be Masking Some Underlying Issues

April 01, 2022
Hadasit Bio-Holdings Ltd's ( TLV:HDST ) healthy profit numbers didn't contain any surprises for investors. We think...
  • 1

Make Confident Investment Decisions

Simply Wall St's Editorial Team provides unbiased, factual reporting on global stocks using in-depth fundamental analysis.
Find out more about our editorial guidelines and team.

Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
  • About
  • Careers
  • Plans
  • Log In
  • Help Centre
  • Latest Coverage
  • Podcasts
  • Financial Services Guide
  • Terms and Conditions
  • Privacy Policy

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.